Fortis Healthcare: Subsidiary Fortis Hospitals Gets ₹117.04 Cr Income Tax Demand For AY25, Company Reviews Appeal Options

 28 Mar 2026 02:57 PM

Fortis Healthcare: Subsidiary Fortis Hospitals Gets ₹117.04 Cr Income Tax Demand For AY25, Company Reviews Appeal Options

Citi stays bullish on Fortis Healthcare, reiterates Buy with target price at ₹1,120

 17 Feb 2026 09:00 AM

Citi stays bullish on Fortis Healthcare, reiterates Buy with target price at ₹1,120

UBS on Fortis Healthcare Buy, TP Rs 1150

 17 Feb 2026 09:01 AM

UBS on Fortis Healthcare Buy, TP Rs 1150

Fortis Healthcare: IHH Healthcare Increases Investment In Fortis Healthcare Through Preferential Allotment To Pay Off Debt And Support Growth

 16 Feb 2026 12:09 PM

Fortis Healthcare: IHH Healthcare Increases Investment In Fortis Healthcare Through Preferential Allotment To Pay Off Debt And Support Growth

Fortis Healthcare: Expects 4-5% Growth In Average Revenue Per Occupied Bed Over The Next 2 Years.

 16 Feb 2026 11:44 AM

Fortis Healthcare: Expects 4-5% Growth In Average Revenue Per Occupied Bed Over The Next 2 Years.

Fortis Healthcare: Reports 17% YOY Revenue Growth For October To December, With EBITDA Margin At 22.3%; Anticipates Continued Revenue And Margin Growth Over The Next Two Years, Along With Margin Improvement From Bed Expansion In FY27.

 16 Feb 2026 11:42 AM

Fortis Healthcare: Reports 17% YOY Revenue Growth For October To December, With EBITDA Margin At 22.3%; Anticipates Continued Revenue And Margin Growth Over The Next Two Years, Along With Margin Improvement From Bed Expansion In FY27.

Fortis Healthcare: Plans To Increase 400 Beds In Current Hospitals By FY27.

 16 Feb 2026 11:25 AM

Fortis Healthcare: Plans To Increase 400 Beds In Current Hospitals By FY27.

Citi maintains 'Buy' ratings on Fortis Health with a target price of Rs 1,120.

 16 Feb 2026 09:00 AM

Citi maintains 'Buy' ratings on Fortis Health with a target price of Rs 1,120.

FORTIS HEALTHCARE: Q3 CONS NET PROFIT 1.9B RUPEES VS 2.5B (YOY); EST 2.6B || Q3 REVENUE 22.65B RUPEES VS 19.3B (YOY)

 13 Feb 2026 08:23 PM

FORTIS HEALTHCARE: Q3 CONS NET PROFIT 1.9B RUPEES VS 2.5B (YOY); EST 2.6B || Q3 REVENUE 22.65B RUPEES VS 19.3B (YOY)

FORTIS HEALTHCARE: Q3 EBITDA 5.06B RUPEES VS 3.75B (YOY) || Q3 EBITDA MARGIN 22.32% VS 19.45% (YOY)

 13 Feb 2026 08:24 PM

FORTIS HEALTHCARE: Q3 EBITDA 5.06B RUPEES VS 3.75B (YOY) || Q3 EBITDA MARGIN 22.32% VS 19.45% (YOY)

Fortis Healthcare: Delhi High Court Issues Criminal Complaint Due To Forged Term Sheet In Fortis-Walmark Dispute.

 22 Jan 2026 02:57 PM

Fortis Healthcare: Delhi High Court Issues Criminal Complaint Due To Forged Term Sheet In Fortis-Walmark Dispute.

Fortis Healthcare: NCLT Allows Co's Wholly Owned Subsidiaries To Merge With Fortis Hospitals Limited Starting April 1, 2022, Pending ROC Registrations

 16 Jan 2026 08:11 PM

Fortis Healthcare: NCLT Allows Co's Wholly Owned Subsidiaries To Merge With Fortis Hospitals Limited Starting April 1, 2022, Pending ROC Registrations

Fortis Healthcare: Co Plans Aggressive Expansion of Over 3,200 Beds by 2030; Making Strategic Acquisitions in Bangalore and Punjab; Closure of IHH Open Offer; Growth in Medical Tourism; Increasing ARPOB and Occupancy Rates; Focus on Diagnostic B2C Segment - Investor Presentation

 08 Jan 2026 11:31 AM

Fortis Healthcare: Co Plans Aggressive Expansion of Over 3,200 Beds by 2030; Making Strategic Acquisitions in Bangalore and Punjab; Closure of IHH Open Offer; Growth in Medical Tourism; Increasing ARPOB and Occupancy Rates; Focus on Diagnostic B2C Segment - Investor Presentation

Fortis Healthcare: Co's arm, IHL, has finalized agreements to buy TMI Healthcare and its hospital properties

 20 Dec 2025 12:41 PM

Fortis Healthcare: Co's arm, IHL, has finalized agreements to buy TMI Healthcare and its hospital properties

Fortis Healthcare: Goldman Sachs on Fortis Healthcare - Neutral, Target Price Rs 965

 08 Dec 2025 09:01 AM

Fortis Healthcare: Goldman Sachs on Fortis Healthcare - Neutral, Target Price Rs 965

FORTIS HEALTHCARE: Q2 CONS NET PROFIT 3.2B RUPEES VS 1.76B (YOY) || Q2 REVENUE 23.3B RUPEES VS 19.9B (YOY)

 11 Nov 2025 08:19 PM

FORTIS HEALTHCARE: Q2 CONS NET PROFIT 3.2B RUPEES VS 1.76B (YOY) || Q2 REVENUE 23.3B RUPEES VS 19.9B (YOY)

FORTIS HEALTHCARE: Q2 EBITDA 5.6B RUPEES VS 4.35B (YOY) || Q2 EBITDA MARGIN 23.86% VS 21.87% (YOY)

 11 Nov 2025 08:20 PM

FORTIS HEALTHCARE: Q2 EBITDA 5.6B RUPEES VS 4.35B (YOY) || Q2 EBITDA MARGIN 23.86% VS 21.87% (YOY)